Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 19 May 2014 for Acura Pharmaceuticals, INC, €1,794.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -33.8%Entry US$6.00 · Close at T+365 US$3.97
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
J. Bradley Rivet: trading record in brief
Our data holds just one disclosure by J. Bradley Rivet, dated 19 May 2014, reporting an open-market purchase worth €1,794 in Acura Pharmaceuticals, Inc. Further filings will be added here. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to J. Bradley Rivet
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 2,000 shares@ US$1.23Common StockSEC:0001144204-14-032050:0Canonical exit: 17 Aug 2014 (T+90)
1 of 1 declaration
